Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Prostate Cancer Metastatic × Lenograstim × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 2 Prostate Cancer Metastatic 1 Multiple Myeloma 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia, Myeloid, Acute 1

Interventions

enzalutamide 2 cabazitaxel 2 Prednisone 2 Androgen Antagonists 2 fludrocortisone acetate 1 darolutamide 1 XRP6258 1 Radiosurgery 1 Pluvicto 1 Lutetium-177 1 Lutetium 1 Lenograstim 1 Hydrocortisone 1 Granulocyte Colony-Stimulating Factor 1 Docetaxel 1 Dexamethasone 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02961257 2022-05-12

CABASTY

Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie

Phase 3 Completed

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡